Trial intelligence / Profile preview

Dimdazenil vs estazolam for daytime function in insomnia

ChiCTR2600125429Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Sun Yat-sen University
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dimdazenil in Insomnia (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Change in Flinders Fatigue Scale score from baseline to Day 14. Planned start May 2026; status: not yet recruiting.

02

Drugs

dimdazenil
03

Conditions

Insomnia

Beyond the preview

Go deeper on ChiCTR2600125429.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600125429.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call